Exact Mass: 500.1565

Nocardicin A

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

(S)-N-[3-(3,4-Methylenedioxyphenyl)-2-(acetylthio)methyl-1-oxoprolyl]-(S)-alanine benzyl ester

C25H28N2O7S (500.1617)

Nocardicin B

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

Orcein

C28H24N2O7 (500.1583)

Once used as a food colouring but now banned throughout the EC Cudbear is a dye extracted from orchil lichens that produces colours in the purple range. It can be used to dye wool and silk, without the use of mordant. Cudbear was the first dye to be invented in modern times, and one of the few dyes to be credited to a named individual. Orcinol is extracted from archil lichen, Rocella tinctoria. It is then converted to orcein by ammonia and air. Orcein is a reddish-brown dye, orchil is a purple-blue dye. Orcein is also used as a stain in microscopy to visualize elastic fibers,Hepatitis B surface antigens and copper associated proteins. It is a mixture of phenoxazone derivates - hydroxyorceins, aminoorceins, and aminoorceinimines.

(E)-N-(2-(((3-(4-Chlorophenyl)allyl)(methyl)amino)methyl)phenyl)-N-(2-hydroxyethyl)-4-methoxybenzenesulfonamide

C26H29ClN2O4S (500.1536)

Nocardicin A

C23H24N4O9 (500.1543)

Simotinib

C25H26ClFN4O4 (500.1627)

Curtisian P

C29H24O8 (500.1471)

Gnetuhainin J

C29H24O8 (500.1471)

Guibourtinidol-(4alpha-

C29H24O8 (500.1471)

Gericudranin D

C29H24O8 (500.1471)

MEGxp0_000848

C22H28O13 (500.153)

1,4,5-trihydroxynaphthalene 1,4-di-O-beta-D-glucopyranoside|5-hydroxynaphthalene-1,4-di-O-beta-D-glucopyranoside|juglanoside F

C22H28O13 (500.153)

ST077077

C22H28O13 (500.153)

(E)-2-(6-(bis(4-hydroxyphenyl)methylene)-5-(4-hydroxyphenyl)cyclohexa-2,4-dienylidene)-1-(4-hydroxyphenyl)ethanone|selaginellin G

C33H24O5 (500.1624)

C22H28O13

C22H28O13 (500.153)

Diospyrosid

C22H28O13 (500.153)

5-Methylcoumarin-4-cellobioside

C22H28O13 (500.153)

gnetoflavanol E

C29H24O8 (500.1471)

5-Methylcoumarin-4-gentiobioside

C22H28O13 (500.153)

Guibourtinidol-(4alpha->2)-3,5,3,4-tetrahydroxystilbene

C29H24O8 (500.1471)

gneafricanin A

C29H24O8 (500.1471)

(6-trans-p-coumaroyl)-3-O-beta-D-glucopyranosyl-(5-acetyl)-2-deoxy-D-ribonic acid

C22H28O13 (500.153)

Lawsoniaside

C22H28O13 (500.153)

gnetoflavanol B

C29H24O8 (500.1471)

1,4,5-trihydroxynaphthalene 1,5-di-O-beta-D-glucopyranoside|juglanoside G

C22H28O13 (500.153)

gneafricanin B

C29H24O8 (500.1471)

Drynachromoside A

C22H28O13 (500.153)

Haploperoside C

C22H28O13 (500.153)

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.543 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.542

6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one

C22H28O13 (500.153)

C22H28O13_3-[6-({6-O-[(2R,3R,4R)-3,4-Dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranosyl}oxy)-1-benzofuran-5-yl]propanoic acid

C22H28O13 (500.153)

6-methoxy-7-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-2-one

C22H28O13 (500.153)

Cys Asp Thr Tyr

C20H28N4O9S (500.1577)

Cys Asp Tyr Thr

C20H28N4O9S (500.1577)

Cys Glu Ser Tyr

C20H28N4O9S (500.1577)

Cys Glu Tyr Ser

C20H28N4O9S (500.1577)

Cys Ser Glu Tyr

C20H28N4O9S (500.1577)

Cys Ser Tyr Glu

C20H28N4O9S (500.1577)

Cys Thr Asp Tyr

C20H28N4O9S (500.1577)

Cys Thr Tyr Asp

C20H28N4O9S (500.1577)

Cys Tyr Asp Thr

C20H28N4O9S (500.1577)

Cys Tyr Glu Ser

C20H28N4O9S (500.1577)

Cys Tyr Ser Glu

C20H28N4O9S (500.1577)

Cys Tyr Thr Asp

C20H28N4O9S (500.1577)

Asp Cys Thr Tyr

C20H28N4O9S (500.1577)

Asp Cys Tyr Thr

C20H28N4O9S (500.1577)

Asp Asp Asp His

C18H24N6O11 (500.1503)

Asp Asp His Asp

C18H24N6O11 (500.1503)

Asp His Asp Asp

C18H24N6O11 (500.1503)

Asp Thr Cys Tyr

C20H28N4O9S (500.1577)

Asp Thr Tyr Cys

C20H28N4O9S (500.1577)

Asp Tyr Cys Thr

C20H28N4O9S (500.1577)

Asp Tyr Thr Cys

C20H28N4O9S (500.1577)

Glu Cys Ser Tyr

C20H28N4O9S (500.1577)

Glu Cys Tyr Ser

C20H28N4O9S (500.1577)

Glu Ser Cys Tyr

C20H28N4O9S (500.1577)

Glu Ser Tyr Cys

C20H28N4O9S (500.1577)

Glu Tyr Cys Ser

C20H28N4O9S (500.1577)

Glu Tyr Ser Cys

C20H28N4O9S (500.1577)

His Asp Asp Asp

C18H24N6O11 (500.1503)

Ser Cys Glu Tyr

C20H28N4O9S (500.1577)

Ser Cys Tyr Glu

C20H28N4O9S (500.1577)

Ser Glu Cys Tyr

C20H28N4O9S (500.1577)

Ser Glu Tyr Cys

C20H28N4O9S (500.1577)

Ser Tyr Cys Glu

C20H28N4O9S (500.1577)

Ser Tyr Glu Cys

C20H28N4O9S (500.1577)

Thr Cys Asp Tyr

C20H28N4O9S (500.1577)

Thr Cys Tyr Asp

C20H28N4O9S (500.1577)

Thr Asp Cys Tyr

C20H28N4O9S (500.1577)

Thr Asp Tyr Cys

C20H28N4O9S (500.1577)

Thr Tyr Cys Asp

C20H28N4O9S (500.1577)

Thr Tyr Asp Cys

C20H28N4O9S (500.1577)

Tyr Cys Asp Thr

C20H28N4O9S (500.1577)

Tyr Cys Glu Ser

C20H28N4O9S (500.1577)

Tyr Cys Ser Glu

C20H28N4O9S (500.1577)

Tyr Cys Thr Asp

C20H28N4O9S (500.1577)

Tyr Asp Cys Thr

C20H28N4O9S (500.1577)

Tyr Asp Thr Cys

C20H28N4O9S (500.1577)

Tyr Glu Cys Ser

C20H28N4O9S (500.1577)

Tyr Glu Ser Cys

C20H28N4O9S (500.1577)

Tyr Ser Cys Glu

C20H28N4O9S (500.1577)

Tyr Ser Glu Cys

C20H28N4O9S (500.1577)

Tyr Thr Cys Asp

C20H28N4O9S (500.1577)

Tyr Thr Asp Cys

C20H28N4O9S (500.1577)

KN-93

C26H29ClN2O4S (500.1536)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

Nap-TyrMe-OH

C28H24N2O7 (500.1583)

Tyr-Nap-OH

C28H24N2O7 (500.1583)

Orcein

C28H24N2O7 (500.1583)

D004396 - Coloring Agents

4-methylumbelliferyl-beta-d-lactoside

C22H28O13 (500.153)

4-Methylumbelliferyl beta-D-cellobioside

C22H28O13 (500.153)

5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYLPYRAZOLE-3-CARBOXYLICACID

C27H34BrO2P (500.148)

Simotinib

C25H26ClFN4O4 (500.1627)

Eotube

C20H28N4O9S (500.1577)

Haploperoside

C22H28O13 (500.153)

A natural product found in Citropsis articulata.

Quaterrylene

C40H20 (500.1565)

5-hydroxy-2-methylchromone-7-O-rutinoside

C22H28O13 (500.153)

A disaccharide derivative that consists of 5-hydroxy-2-methylchromone substituted by a rutinosyl group at position 7 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits antineoplastic activity.

(2S)-2-amino-4-[4-[(E)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-hydroxycarbonimidoyl]phenoxy]butanoic acid

C23H24N4O9 (500.1543)

(3S,alphaR)-3-[[[4-[(R)-3-Amino-3-carboxypropoxy]phenyl]-[(Z)-hydroxyimino]acetyl]amino]-alpha-(4-hydroxyphenyl)-2-oxo-1-azetidineacetic acid

C23H24N4O9 (500.1543)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

2-[cyclopentyl-[1-oxo-2-(5-thiophen-2-yl-2-tetrazolyl)ethyl]amino]-N-(2-oxolanylmethyl)-2-thiophen-2-ylacetamide

C23H28N6O3S2 (500.1664)

2-[4-(4-methoxyphenyl)-4-methyl-2,5-dioxo-1-imidazolidinyl]-N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide

C27H24N4O4S (500.1518)

N-[(2R,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2R,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3R)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

N-[(2S,3S)-4-[(4-chlorophenyl)sulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide

C23H30ClFN2O5S (500.1548)

(2S)-2-ammonio-4-{4-[(1Z)-2-({(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}amino)-N-hydroxy-2-oxoethanimidoyl]phenoxy}butanoate

C23H24N4O9 (500.1543)

Isonocardicin A

C23H24N4O9 (500.1543)

A nocardicin in which the beta-lactam moiety is substituted at position 1 by a carboxy(4-hydroxyphenyl)methyl group and at position 3 by a [(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetyl]nitrilo group in which the phenolic hydroxy group is substituted by a (3S)-3-amino-3-carboxypropyl group.

isonocardicin A zwitterion

C23H24N4O9 (500.1543)

An L-alpha-amino acid zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of isonocardicin A.

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

(11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-triene-8,11-diol

C29H24O8 (500.1471)

5-[(2s,3s)-7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl]benzene-1,3-diol

C29H24O8 (500.1471)

(1e,2r,3r)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(2s,3r,4s,5s,6r)-2-[(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

4-[(2s,3s)-3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

7-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one

C22H28O13 (500.153)

7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O13 (500.153)

3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

6,7-dihydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate

C22H28O13 (500.153)

(4s,5s,11s,12r)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

5-methylcoumarin-4-cellobioside

C22H28O13 (500.153)

{"Ingredient_id": "HBIN011802","Ingredient_name": "5-methylcoumarin-4-cellobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14248","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "196631","DrugBank_id": "NA"}

5-methylcoumarin-4-gentiobioside

C22H28O13 (500.153)

{"Ingredient_id": "HBIN011803","Ingredient_name": "5-methylcoumarin-4-gentiobioside","Alias": "NA","Ingredient_formula": "C22H28O13","Ingredient_Smile": "CC1=C2C(=CC=C1)OC(=O)C=C2OC3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)O","Ingredient_weight": "500.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14249","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "3080987","DrugBank_id": "NA"}

(1z,2s,3s)-3-(3,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

(2r,3r,4r)-4-{2-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

(2r)-2-amino-4-{4-[(e)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

(2s,3r,4s,5s,6r)-2-[(4-hydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,3-diol

C29H24O8 (500.1471)

(2s)-2-amino-4-{4-[(z)-{[(3s)-1-[(s)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

(2s,3r,4s,5s,6r)-2-[(5-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

7-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-methoxychromen-2-one

C22H28O13 (500.153)

6-(acetyloxy)-2,4',5-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl 3-phenylpropanoate

C29H24O8 (500.1471)

4-{2-[2-(3,4-dihydroxyphenyl)ethenyl]-4,6-dihydroxyphenyl}-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol

C29H24O8 (500.1471)

2,4-dihydroxy-7-(4-hydroxy-2-methoxy-6-methylphenyl)-9-methoxy-12,12-dimethyltetracene-5,6,11-trione

C29H24O8 (500.1471)

(1r,4s,5r,6s,7r,8s,9s)-4,5-dihydroxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate

C22H28O13 (500.153)

4,5-dihydroxy-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-6-yl 4-hydroxybenzoate

C22H28O13 (500.153)

(1e,2s,3s)-3-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-1-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydroindene-4,6-diol

C29H24O8 (500.1471)

4-[3-(3,5-dihydroxyphenyl)-4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]-2,3-dihydro-1-benzofuran-2-yl]benzene-1,2-diol

C29H24O8 (500.1471)

(11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

6-methoxy-7-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]chromen-2-one

C22H28O13 (500.153)

2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(4s,5s,11r,12s)-5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

6-methoxy-7-{[(2s,3r,4s,5s)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}chromen-2-one

C22H28O13 (500.153)

6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(2s)-2-{[(1,3-dimethyl-2,4-dioxopteridin-6-yl)(hydroxy)methylidene]amino}-n-[2-(methoxycarbonyl)phenyl]-4-(methylsulfanyl)butanimidic acid

C22H24N6O6S (500.1478)

(5r,6r,11s,12r)-6-(3,5-dihydroxyphenyl)-5,12-bis(4-hydroxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-triene-8,11-diol

C29H24O8 (500.1471)

(2r,3r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

5-(3,5-dihydroxyphenyl)-4,11-bis(4-hydroxyphenyl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-triene-7,12-diol

C29H24O8 (500.1471)

3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(4-hydroxyphenyl)methyl]-2,3-dihydro-1-benzopyran-4-one

C29H24O8 (500.1471)

(1s,4ar,5s,6r,7s,7as)-6,7-dihydroxy-7-(hydroxymethyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate

C22H28O13 (500.153)

(2r)-2-amino-4-{4-[(z)-{[(3s)-1-[(r)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

5-{7-[(1e)-2-(3,5-dihydroxyphenyl)ethenyl]-6-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1-benzofuran-3-yl}benzene-1,3-diol

C29H24O8 (500.1471)

2-amino-4-{4-[(z)-({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

2-amino-4-{4-[({1-[carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid

C23H24N4O9 (500.1543)

2-[(4-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)

7-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)-3,4,5-trihydroxy-3-methyloxan-2-yl]oxy}-6-hydroxychromen-2-one

C22H28O13 (500.153)

(1r,2s,3e)-1-(2,4-dihydroxyphenyl)-2-(3,5-dihydroxyphenyl)-3-[(4-hydroxy-3-methoxyphenyl)methylidene]-1,2-dihydroindene-5,6-diol

C29H24O8 (500.1471)

2-[(5-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C22H28O13 (500.153)